197 related articles for article (PubMed ID: 26005019)
1. Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study.
Kurzepa J; Szpetnar M; Hordyjewska A; Wątroba S; Gołąb P; Boguszewska-Czubara A
Neurol Res; 2015 Oct; 37(10):934-7. PubMed ID: 26005019
[TBL] [Abstract][Full Text] [Related]
2. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
Gołąb P; Boguszewska-Czubara A; Kiełbus M; Kurzepa J
Neurol Neurochir Pol; 2014; 48(5):309-14. PubMed ID: 25440008
[TBL] [Abstract][Full Text] [Related]
3. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
4. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.
Jauss M; Schütz HJ; Tanislav C; Misselwitz B; Rosenow F
Eur J Neurol; 2010 Apr; 17(4):555-61. PubMed ID: 20218973
[TBL] [Abstract][Full Text] [Related]
5. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
[TBL] [Abstract][Full Text] [Related]
6. Actylise treatment does not influence nitric oxide metabolites serum level.
Horecka A; Szpetnar M; Hordyjewska A; Babula D; Gołąb P; Kurzepa J
Pharmacol Rep; 2016 Jun; 68(3):598-600. PubMed ID: 26971035
[TBL] [Abstract][Full Text] [Related]
7. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive.
Kerr DM; Fulton RL; Higgins P; Bath PM; Shuaib A; Lyden P; Lees KR;
Stroke; 2012 Feb; 43(2):399-404. PubMed ID: 22075999
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
9. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.
Leys D; Hommet Y; Jacquet C; Moulin S; Sibon I; Mas JL; Moulin T; Giroud M; Sagnier S; Cordonnier C; Medeiros de Bustos E; Turc G; Ronzière T; Bejot Y; Detante O; Ouk T; Mendyk AM; Favrole P; Zuber M; Triquenot-Bagan A; Ozkul-Wermester O; Montoro FM; Lamy C; Faivre A; Lebouvier L; Potey C; Poli M; Hénon H; Renou P; Dequatre-Ponchelle N; Bodenant M; Debruxelles S; Rossi C; Bordet R; Vivien D;
Neurology; 2016 Dec; 87(23):2416-2426. PubMed ID: 27815401
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
Gosser RA; Arndt RF; Schaafsma K; Dang CH
J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
[TBL] [Abstract][Full Text] [Related]
13. Very early mobilization in stroke patients treated with intravenous recombinant tissue plasminogen activator.
Arnold SM; Dinkins M; Mooney LH; Freeman WD; Rawal B; Heckman MG; Davis OA
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1168-73. PubMed ID: 25869770
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
15. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
[TBL] [Abstract][Full Text] [Related]
16. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
17. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
19. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
[TBL] [Abstract][Full Text] [Related]
20. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
